1. Abboud, F. M., Eckstein, J. W., Lawrence, M. S., and Hoak, J. C., 1967, Preliminary observations on the use of intra-arterial reserpine in Raynaud’s phenomenon, Circulation (Suppl. 2) 36: 49.
2. Ahlbaum, H. G., and Milch, L. J., 1962, The effect of central nervous system drugs on the incorporation of radioactive carbon into brain adenosine triphosphate (ATP), Ann. N.Y. Acad. Sci. 96: 190.
3. Alpers, H. S., and Shore, P. A., 1969, Specific binding of reserpine—Association with no-repinephrine depletion, Biochem. Pharmacol. 18: 1363.
4. Andén, N.-E., and Lundborg, P., 1970, Recovery of the amine uptake-storage mechanism in nerve granules after reserpine treatment: Inhibition by axotomy, J. Pharm. Pharmacol. 22: 233.
5. Andén, N.-E., Roos, B.-E., and Werdinius, B., 1963, 3,4-Dihydroxyphenylacetic acid in rabbit corpus striatum normally and after reserpine treatment, Life Sci. 2: 319.